Prognosis Relevance of Serum Cytokines in Pancreatic Cancer

The overall survival of patients with pancreatic ductal adenocarcinoma is extremely low. Although gemcitabine is the standard used chemotherapy for this disease, clinical outcomes do not reflect significant improvements, not even when combined with adjuvant treatments. There is an urgent need for pr...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biomed Res Int
Autori principali: Torres, Carolina, Linares, Ana, Alejandre, Maria José, Palomino-Morales, Rogelio J., Caba, Octavio, Prados, Jose, Aránega, Antonia, Delgado, Juan R., Irigoyen, Antonio, Martínez-Galán, Joaquina, Ortuño, Francisco M., Rojas, Ignacio, Perales, Sonia
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi Publishing Corporation 2015
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4539422/
https://ncbi.nlm.nih.gov/pubmed/26346854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/518284
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi